Since 2018 Kedrion has had exclusive distribution rights in the US for KEDRAB®, a Human Rabies Immune Globulin developed in partnership with Kamada Ltd.New agreement becomes effective in January.
Priority Review of the Gadopiclenol NDA granted by the U.S. Food and Drug Administration" MILAN, March 31, 2022 /PRNewswire/ Bracco is very excited about the Priority Review granted
Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications - read this article along with other careers information, tips and advice on BioSpace